Potential treatment for terminal cancer

Posted: by on 11/10/10

More on these Topics:

Text to go here...

mouse–mice–lab.jpgFor the first time, researchers have discovered a therapy that can treat the invariably lethal terminal stages of cancer in animals. The new monoclonal antibody is effective in mice against colon and breast cancers and melanoma and does not appear to have any toxic effects.

Currently, the end stages of metastatic cancer - secondary cancers that have already spread to other parts of the body from original locations - are untreatable. Many patients die because of the progressively debilitating, organ-destroying qualities of secondary cancer.

In this research scientists created a monoclonal antibody that specifically blocks an adhesion molecule called PECAM-1. The researchers found treatment with the antibody effectively treats the terminal stages of cancer, with tumours shrinking and treated animals gaining weight.

Last edited: 11 January 2022 10:18

Back to News

Get the latest articles and news from Understanding Animal Research in your email inbox every month.
For more information, please see our privacy policy.